Air pollution exposure during pregnancy may result in physical growth delays after birth, according to a new study by the Barcelona Institute for Global Health.
Air pollution exposure during pregnancy may result in physical growth delays after birth, according to a new study by the Barcelona Institute for Global Health (ISGlobal). Researchers added that the growth effects may be lasting and could require follow-up as the child ages.
According to the World Health Organization (WHO), nearly 90% of people worldwide breathe polluted air. Prenatal air pollution exposure is known to cause significant health risks in children, such as lower birth weight and adverse respiratory outcomes. However, little research has evaluated its impact on postnatal and early childhood growth.
The comprehensive Spanish study, published in Environmental International, was conducted to expand current knowledge of prenatal air pollution exposure and explore its associations with physical growth and cardio-metabolic risk factors in postnatal and early childhood.
Researchers used data from the Environment and Childhood Project, a Spanish network of birth cohorts known as Infancia y Medio Ambiente (INMA), to analyze 2,765 pregnant mother-child dyads (N=1,724) in the first trimester of pregnancy. Women were recruited between 2003 and 2008. First-trimester nitrogen dioxide (NO2) and fine particles (PM2.5) exposure levels were estimated. Child height, weight, waist circumference, blood pressure, and lipids were measured at 4 years, and body mass index (BMI) trajectories were recorded from birth to 4 years.
The results of this study of many growth and cardio-metabolic risk-related outcomes suggest that increased PM2.5 exposure in the first trimester was associated with decreased weight and BMI. Higher NO2 and PM2.5 exposure was associated with a reduced risk of accelerated BMI trajectory.
The authors concluded that air pollution exposure during pregnancy may result in physical growth delays in the early years after birth. They also noted that these adverse effects were lasting after birth and could require follow-up in later years of childhood.
The study and its findings ultimately highlight that pregnant women should be considered a priority when creating public health policies.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More